Orally Disintegrating Tablet






ONDANSETRON DISINTEGRATING TABLET - ORAL (Zofran ODT

6/14/2014
04:40 | Author: Alexander Anderson

Orally Disintegrating Tablet
ONDANSETRON DISINTEGRATING TABLET - ORAL (Zofran ODT

Consumer information about the medication ONDANSETRON DISINTEGRATING TABLET - ORAL (Zofran ODT), includes side effects, drug interactions.

Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

The brain. The body. The bedroom. What do you know? View Quiz » Weight Loss The No-Diet Approach Learn More »

HOW TO USE: This medication is dissolved on top of the tongue. It is not meant to be chewed or swallowed like other tablet forms.Dry your hands before using this medication.

Comments (1)Read more



Ondansetron orally disintegrating tablets Indications, Side Effects

4/13/2014
02:40 | Author: Alexander Anderson

Orally Disintegrating Tablet
Ondansetron orally disintegrating tablets Indications, Side Effects

Easy to read patient leaflet for ondansetron orally disintegrating tablets. Includes indications, proper use, special instructions, precautions, and possible side.

Nausea / Vomiting, Chemotherapy Induced lorazepam, Ativan, Zofran, ondansetron, Reglan, dexamethasone, More.

Some medical conditions may interact with ondansetron orally disintegrating tablets. l your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products.

Comments (2)Read more

Orally Disintegrating Tablets - Medscape

12/22/2014
10:40 | Author: Alexander Anderson

Orally Disintegrating Tablet
Orally Disintegrating Tablets - Medscape

Orally disintegrating, or orodispersible, tablets (ODTs) are designed to dissolve in the presence of saliva within one minute. The primary advantage of ODTs is.

Medscape uses cookies to customize the site based on the information we collect at registration. The cookies contain no personally identifiable information and have no effect once you leave the Medscape site.

Medscape: Medscape Access In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.

Comments (0)

Orally Disintegrating Tablets - Pharmaceutical Technology

10/21/2014
08:00 | Author: Alexander Anderson

Orally Disintegrating Tablet
Orally Disintegrating Tablets - Pharmaceutical Technology

This review article discusses orally disintegrating tablets and their manufacturing technologies, development issues, and future trends.

Latest Issue PharmTech.

Latest Issue PharmTech Europe.

Eyewire Over the past three decades, orally disintegrating tablets (ODTs) have gained much attention as a preferred alternative to conventional oral dosage forms such as tablets and capsules. An ODT is a solid dosage form that disintegrates and dissolves in the mouth (either on or beneath the tongue or in the buccal cavity) without water within 60 seconds or less. The US Food and Drug Administration Center for Drug Evaluation and Research (CDER) defines in the Orange Book an ODT as "A solid dosage form containing medicinal substances, which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue" (1).

Comments (4)Read more

Reglan ODT (Metoclopramide Orally Disintegrating Tablets) Drug

8/20/2014
06:40 | Author: Alexander Anderson

Orally Disintegrating Tablet
Reglan ODT (Metoclopramide Orally Disintegrating Tablets) Drug

Learn about the prescription medication Reglan ODT (Metoclopramide Orally Disintegrating Tablets), drug uses, dosage, side effects, drug interactions.

Report Problems to the Food and Drug Administration.

Read All Potential Side Effects and See Pictures of Reglan ODT »

Treatment with metoclopramide for longer than 12 weeks should be avoided in all but rare cases where therapeutic benefit is thought to outweigh the risk of developing tardive dyskinesia.

"The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease (GERD) in adults and adolescents (ages 12 and up).

Comments (5)Read more